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Type IV secretion systems are multi-protein complexes that transfer macromolecules across the cell
envelope of bacteria. Identifying the sites of interaction between the twelve proteins (VirB1–VirB11
and VirD4) that form these complexes is key to understanding their assembly and function. We have
here used phage display, bacterial two-hybrid and ﬂuorescence-based interaction assays to identify
an N-terminal domain of the inner membrane protein VirB6 as a site of interaction with the
envelope-spanning VirB10 protein. Our results are consistent with the notion that VirB6 acts in con-
cert with VirB10 as well as with VirB8 during secretion system assembly and function.
 2015 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Type IV secretion systems (T4SS) are used by Gram-negative
bacteria to transfer DNA and protein substrates across the cell
envelope into target cells [1,2]. They usually consist of 12 proteins,
VirB1–11 and VirD4, which assemble into a multi-protein channel
that has anchoring points at both the inner and the outer mem-
brane. The overall architecture was ﬁrst determined for the outer
part of the plasmid pKM101-T4SS using cryo-electron microscopy
and X-ray crystallography and it was found to be composed of
homologs of VirB7, VirB9 and the C-terminal domain of VirB10
[3,4]. Analysis of the cryo-electron microscopic structure of the
plasmids R388 T4SS revealed the overall structure of the inner
membrane part of the channel and showed the localization of
VirB4 [5]. However, the exact topologies and the nature of the
interactions between the proteins forming the inner membrane
complex (VirB6, VirB8 and VirB10) remain unknown.In this work, we have focused on the analysis of the interaction
between VirB6 and VirB10. VirB6 is a polytopic inner membrane
protein essential for substrate secretion. It is one of the channel
subunits that is likely in direct contact with the DNA substrate dur-
ing its transfer across the inner membrane [6]. The DNA transfer
assays suggested that VirB6 acts in concert with VirB8 and we have
provided direct evidence for this notion identifying a presumably
periplasmic loop of VirB6 as site of interaction [7]. So far, no struc-
tural information is available for VirB6-like proteins, but the
homologous proteins ComB6 from Helicobacter pylori and VirB6
from Agrobacterium tumefaciens have been characterized using bio-
chemical and genetic approaches [8,9]. They are highly hydropho-
bic proteins, which contain ﬁve transmembrane segments and a
large periplasmic loop located in their central region. The
N-terminal domain of both VirB6 homologs is located in the
periplasm.
VirB10 is another essential component of the T4SS and being
anchored both to the inner and the outer membranes it spans
the entire translocation channel. The crystal structure of the
C-terminal domain of the VirB10 homolog TraF was characterized
in the context of the outer membrane core complex formed by
TraN–TraO–TraF (VirB7–VirB9–VirB10) [3]. According to this struc-
ture, the outer membrane channel is primarily formed by 14 copies
of VirB10, which makes direct contacts with VirB9 and VirB7 in the
external part of the channel. This architecture was surprising as the
seminal studies using DNA immunoprecipitation had failed to
show a direct contact between VirB10 and the translocated
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homologs VirB3 to VirB10 was recently characterized by
cryo-electron microscopy [5]. 24 copies of VirB6 and 14 copies of
VirB10 were found to be forming part of the assembly. However,
this analysis did not reveal the localization of VirB6 or the
N-terminal domain of VirB10 within the inner membrane complex.
VirB6 and VirB10 have also been studied from a functional per-
spective. VirB6 is essential for substrate interactions and substrate
transfer to other VirB proteins [8]. Transferring of substrate from
VirB6 and VirB8 to VirB2 and VirB9 depends on VirB10 [6] and
its efﬁciency is affected by the conformational change undergone
by VirB10 upon ATP binding to the T4SS energizing proteins
VirD4 and VirB11 [10]. Despite these data suggesting close func-
tional links, no evidence was available for a direct interaction
between VirB6 and VirB10. To address this question, we used a
combination of biochemical and genetic interaction assays to iden-
tify speciﬁc VirB10-interacting regions within VirB6 from the
model organism Brucella. Our results show that the N-terminal
region of VirB6 interacts with VirB10. In combination with previ-
ous data from our group [7] these results suggest that VirB6 inter-
acts simultaneously with VirB8 and with VirB10.
2. Materials and methods
2.1. Plasmid, strain constructions and mutagenesis
DNA manipulations followed standard procedures [11]. The
strains and plasmids used are given in Table 1 (Supplementary
information). Escherichia coli strains JM109 (DE3) and BL21 (DE3)
were used as hosts for cloning and mutagenesis and protein over-
production, respectively.
2.2. Cultivation of bacteria
Cultures of E. coli JM109 for cloning experiments were grown at
37 C in LB medium (1% tryptone, 0.5% yeast extract, 1% NaCl) in
the presence of antibiotics for plasmid propagation (ampicillin
[amp], 100 lg/ml; kanamycin [kan], 50 lg/ml). For protein over-
production, E. coli strain BL21star (kDE3) was grown under aerobic
conditions at 37 C in LB to exponential phase (optical density at
600 nm (OD600) of 0.4–0.8), followed by the addition of 0.5 mM
IPTG (isopropyl-b-D-thiogalactopyranoside) to induce gene expres-
sion. Cultivation under aerobic conditions proceeded at 26 C for
16 h after induction.
2.3. Puriﬁcation of fusion proteins
pHTvirB8sp, pHTvirB10sp (encoding periplasmic domains of
Brucella VirB8 and VirB10) and their variants were transformed
into BL21star (DE3) and protein overproduction and puriﬁcation
were carried out as described previously [12]. Brieﬂy, bacterial
cells were harvested, resuspended in binding buffer (50 mM
sodium phosphate, 300 mM NaCl, 40 mM imidazole, pH 7.4) and
lysed using a One Shot cell disrupter (Constant Systems Inc.) at
27 kPsi. Lysates were subsequently centrifuged twice at
13000 rpm (4 C), ﬁltered through a 0.45 lm membrane, loaded
onto a HisTrap Ni-chelate column (GE Healthcare) and eluted over
a linear 50 ml gradient from 40 to 500 mM imidazole. Proteins
were then concentrated, desalted into TEV buffer (25 mM sodium
phosphate, 125 mM NaCl, 5 mM DTT, pH 7.4) and subjected to
cleavage of the N-terminal His-tag using His-tagged TEV protease
in a ratio of 1:70 for 15 h at 20 C. The solution was diluted ten
times, centrifuged at 13000 rpm (4 C), ﬁltered through a
0.45 lm membrane and passed through a pre-equilibrated
HisTrap Ni-chelate column. The ﬂow through containing cleaved
VirB8 or VirB10 was collected.2.4. Determination of the localization of the VirB6 C-terminus
The gene encoding GFP was fused to the region of virB6 encod-
ing the C-terminus of the protein using the pWarf vector system
and ﬂuorescence emission ( yexc 485 nm yem 512 nm) was mea-
sured as described [13]. The level of protein production was
assessed by quantifying the intensities of the signals corresponding
to the fusion proteins after performing a Western blot using
anti-GFP antiserum (Roche).
2.5. Phage display
Puriﬁed VirB10 (100 lg/mL) in 0.1 M NaHCO3 pH 8.6 was
adsorbed onto polystyrene microtitre plates (Thermo Scientiﬁc)
and incubated at 4 C for 16 h, followed by incubation for 2 h at
37 C with blocking buffer (0.1 M NaHCO3, pH 8.6; 5 mg/ml BSA;
0.02% NaN3). Phage libraries (Ph.D.-12 or Ph.D.-C7C) were diluted
to 4  1010 pfu/ml from the original library (New England
Biolabs, NEB), added to the plate, followed by washing with
TBS-T and elution of VirB10-binding phage using 100 ll of elution
buffer (0.2 M glycine–HCl, pH 2.1; 1 mg/ml BSA). Ampliﬁcation of
phage, phage separation and titering were performed as described
previously [14]. Single-stranded DNAs were isolated from 1.5 ml of
individually isolated plaque supernatant using the QIAprep M13
kit (Qiagen). Forward 1 (50-GTGACGATCCCGCAAAAGCGGCCT-30)
and 96gIII primers (50-CCCTCATAGTTATTAGCGTAACG-30) were
used to amplify the DNA sequence encoding the surface-exposed
peptide. Each PCR product was sequenced to identify the encoded
peptide sequence. Unique peptides were aligned to VirB6 sequence
using Relic server’s MATCH program which uses a default scoring
window of 5 and a threshold score of 13 [15]. Pair-wise similarity
is calculated for each scoring window of residues. We also used
MatchScan (P.D. Pawelek, Concordia University, Montréal) that
allows calculation of peptide similarity using a wide range of resi-
due windows and scores.
2.6. SDS/PAGE and Western blotting
Cells and protein samples were incubated in Laemmli sample
buffer for 5 min at 100 C, followed by SDS–PAGE [16,17].
2.7. Bacterial two-hybrid assay (BTH)
Interactions between VirB6 variants and VirB10 were assessed
in vivo using the BTH system [18]. The genes encoding VirB6 vari-
ants and full length VirB10 were fused to the DNA sequences
encoding the T18 and T25 fragments of the catalytic domain of
Bordetella pertussis adenylate cyclase (AC), and they were
co-expressed in BTH101 AC (cya) deﬁcient cells. The interaction
was detected using the functional complementation between the
two catalytic AC fragments leading to cAMP/b-galactosidase pro-
duction detected using ortho-nitrophenyl-b-D-galactopyranoside
as the substrate. The levels of protein production were assessed
using Western blot analyses with anti-CyaA (3D1) antiserum
(Santa Cruz Biotechnology Inc.).
2.8. Protein labeling
Conjugation reactions of Alexa Fluor 488 (A10254, Invitrogen)
or Alexa Fluor 546 (A10258, Invitrogen) were performed according
to the instructions of the manufacturer. Brieﬂy, 10 ll of a freshly
prepared aqueous solution of the dye (10 mg/ml) was added to
previously reduced protein or peptide dissolved in 100 mM Tris–
HCl pH 7.3, 150 mM NaCl and incubated in the dark for 2 h at room
temperature. Excess probe was quenched by adding a 100-fold
molar excess of dithiotreitol and removed using a Sephadex G-25
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ﬁed using a gel ﬁltration Superdex 75 or Superdex Peptide column.
2.9. Fluorescence measurements
Fluorescence emission spectra were measured at room temper-
ature in 100 mM Tris–HCl pH 7.3, 150 mM NaCl using a Cary
Eclipse spectroﬂuorometer. Excitation wavelength was set to
488 nm and spectra were recorded between 500 and 600 nm.
Fluorescence resonance energy transfer (FRET) was assessed by
the decrease in Alexa ﬂuor 488-labeled VirB10 ﬂuorescence in
the presence of Alexa ﬂuor 546-labeled peptides and calculated
as 1  (F0/F) where F0 and F are the donor emission in the presence
and absence of the acceptor, respectively. KD values were calcu-
lated according to Wang et al. [19]. The concentration of VirB10
was 3 lM. The ﬂuorophore was chemically attached to an extra
Cys residue inserted by mutating the gene at position 57 of
VirB10. VirB10 contains two Cys residues, which in the homolo-
gous protein from A. tumefaciens were shown to form a disulﬁde
bridge essential for protein function [20]. We therefore performed
the labeling under conditions in which disulﬁde bonds are
preserved. The synthetic VirB6-peptides included an extra Cys
residue at their N-terminus used for covalent binding of the
ﬂuorophore and contained the following aminoacid sequences:
IGTSIHNQLNNYVTMVASNTMNMI (peptide I), DAFAGNHGTPSSTIY
QTLDNSLGKGWNIAAMLFEKGDNRGLT (peptide II), and TSIFSGSS
GGGGSGSAKAGGESSYSAGGN (peptide III).Fig. 2. Localization of VirB6 C-terminus. (A) The gene encoding VirB6 was cloned
into pWarf() and pWarf(+) vectors. The resulting constructs code for VirB6 C-
terminally fused to GFP (VirB6-GFP) and VirB6 C-terminally fused to GFP, preceded
by a glycophorin transmembrane segment (VirB6-TMgpA-GFP). The predicted
orientations of the two VirB6 fusions are shown (VirB6 transmembrane helices in
gray, glycophorin transmembrane region in black, loops as black strokes); GFP is
ﬂuorescent only in the cytoplasm. (B) Fluorescence (excitation at 485 nm, emission
at 512 nm) of whole cells expressing VirB6 fusions either in pWarf() or pWarf(+)
relative to the value of optical density at 600 nm was normalized by the level of
protein production assessed by Western blot with GFP-speciﬁc antibodies (not
shown). Values and standard deviation were calculated from three independent
experiments.3. Results and discussion
3.1. Analysis of the topology of VirB6
It is generally accepted that the consensus among different
methods makes the prediction of transmembrane segments more
reliable [21]. We used ﬁve programs to predict the Brucella VirB6
transmembrane topology. All of them predicted seven transmem-
brane segments located in similar regions of the protein (Fig. 1).
Interestingly, Brucella VirB6 (347 amino acids) is signiﬁcantly
longer than its homolog from Agrobacterium (295 amino acids).
The functions of these additional amino acids are unknown, but
the increased length of the hydrophobic portion explains why
the presence of two additional transmembrane segments is pre-
dicted (seven vs ﬁve) and the overall predicted topology is very
similar. One of the methods used (TMHMM) also predicts the ori-
entation of the transmembrane segments [22] and according to
this prediction the VirB6 C-terminus locates in the cytoplasm.Fig. 1. Predicted topology of VirB6. Predicted transmembrane segments are shown as bla
central loop region and the C-terminus are indicated. The ﬁve methods used are listed o
services/TMHMM/; HMMTOP: www.enzim.hu/hmmtop/; DAS: www.sbc.su.se/~miklos/DTo experimentally determine the location of the C-terminus we
performed a reporter assay in which GFP was C-terminally fused to
VirB6. In addition, to assess the possibility of an alternative orien-
tation, we used a control in which a protein fragment providing an
extra transmembrane segment derived from glycophorin A was
inserted between the VirB6 C-terminus and GFP (Fig. 2A) [13].
Normalized ﬂuorescence of cells expressing GFP directly fused to
the VirB6 C-terminus was much higher than that of cells carrying
the alternative construct (Fig. 2B). Since GFP is ﬂuorescent in the
cytoplasm and non-ﬂuorescent when directed to the periplasm,
we conclude that VirB6 C-terminus locates inside the cytoplasm.ck rectangles with residue numbers relative to the N terminus. The N-terminus, the
n the left: SOSUI: http://bp.nuap.nagoya-u.ac.jp/sosui/; TMHMM: www.cbs.dtu.dk/
AS/; and TMpred: www.ch.embnet.org/software/TMPRED_form.html.
Fig. 3. Identiﬁcation of VirB10 binding peptides by phage display. The puriﬁed periplasmic domain of VirB10 was subjected to three rounds of panning using the Ph.D.-C7C
and Ph.D.-12 M13 phage display libraries. The sequences of the afﬁnity-selected peptides were aligned to different regions of the VirB6 sequence using RELIC software [15].
Identical residues are highlighted in black and conserved residues are highlighted in gray.
Fig. 4. In vivo analysis of VirB6 and VirB10 interactions using bacterial two hybrid assay. (A) Full length VirB10 and different domains of VirB6 (fusion after amino acids 58,
142, 168, 235 and 347 (full length) and after the region comprising amino acids 58–168) were expressed as fusions to the T25 and T18 domains of adenylate cyclase,
respectively. (B) The interactions between VirB6 domains and VirB10 were assessed using the bacterial two-hybrid assay measuring b-galactosidase activity. The interaction
between VirB10 and VirB8 [24] was used as the positive control while co-expression of the plasmid expressing T25VirB10 with an empty T18 fusion vector was used as the
negative control. Values and standard deviations were calculated from three independent experiments. The lower panels show the Western blots using anti-Cya antibodies.
Signals shown by arrows correspond to the predicted molecular masses of T18VirB6 1–58 fusion protein in the ﬁrst lane, T18VirB6 1–168 in the third lane, and T18VirB8 in
the last lane. The T25VirB10 fusion protein was equally detected at the predicted molecular mass in the strains expressing these three fusion proteins, signals of lower
molecular masses likely correspond to degradation products.
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tational methods predicting an uneven number of transmembrane
segments, imply that the C-terminal region of VirB6 localizes in the
cytoplasm and that the central loop locates in the periplasm, which
is similar to the topology of Agrobacterium VirB6 [8]. This places
the N-terminus and the central periplasmic loop in the same com-
partment as the periplasmic domains of possible interaction part-
ners VirB8 and VirB10.3.2. VirB10-interacting domains of VirB6 identiﬁed by phage display
To identify VirB10-interacting domains within VirB6 we used
phage display, an unbiased approach aimed at identifying interact-
ing regions using large randomized libraries of peptides displayed
on the surface of phages [14,23]. The puriﬁed periplasmic domain
of VirB10 was ﬁxed on a plate and incubated with M13 phage
libraries displaying random 12-mer peptides (Ph.D.-12 library) or
Fig. 5. Fluorescence resonance energy transfer between VirB6-derived peptides and
VirB10. (A) Fluorescence emission of Alexa ﬂuor 488 (donor) chemically attached to
VirB10 (3 lM) upon increasing concentrations of VirB6-derived peptides labeled
with acceptor ﬂuorophore Alexa ﬂuor 546 (peptide 1: ﬁlled circles, amino acids 10–
33; peptide 2: empty triangles, amino acids 100–143; peptide 3: empty squares,
amino acids 301–329). FRET efﬁciency was calculated as 1  (F0/F) where F0 and F
are the donor emission in the presence and absence of the acceptor, respectively. (B)
Peptides 1–3 (amino acids in black bold print) displayed on a model of the VirB6
structure generated with TOPO2 (http://www.sacs.ucsf.edu/cgi-bin/open-topo2.py)
based on the transmembrane segment prediction using TMHMM (http://www.cbs.
dtu.dk/services/TMHMM/).
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the M13 pIII protein. The binding phages were enriched by three
rounds of panning. Sequencing of the DNA encoding the displayed
peptides identiﬁed 125 unique peptides (Table 2, supplementary
information). The sequences were aligned against VirB6 sequence
using the RELIC server MATCH program [15]. As the phage display
approach is a screening method based on fully randomized peptide
libraries, the selected sequences were not expected to provide
exact matches with interacting proteins. However, this approach
identiﬁed several peptides with similarity to VirB6 that aligned
with different regions of the protein, including the central periplas-
mic loop and the N-terminus (Fig. 3). We next tested these possible
interaction sites using both in vivo and in vitro methods.
3.3. The VirB6 N-terminal domain interacts with VirB10 in vivo
The interaction between VirB10 and VirB6 was next assessed
using the bacterial two-hybrid (BTH) system in which each protein
was fused to the N- or the C-terminal domains of adenylate cyclase
(AC), respectively. The readout of the assay consists of detecting
b-galactosidase activity induced by the cAMP produced by the
resulting enzymatic activity when the N- and C-terminal domains
of AC are brought together by interacting fusion proteins. We
co-expressed different fragments of VirB6 covering the potential
interacting regions (Fig. 4A) fused to the C-terminus of CyaA with
full-length VirB10 fused to the N-terminus of CyaA. VirB8, a known
interaction partner of VirB10 was used as positive control and
co-expression with empty fusion protein vectors were used as neg-
ative control. We detected b-galactosidase activity in strains
expressing VirB6 residues 1–58 and 1–168 fused CyaA, but not in
the case of fusion proteins to other fragments or to full-length
VirB6 (Fig. 4B), suggesting that these regions interact with VirB10.
To determine whether b-galactosidase activities correlated with
the accumulation of VirB6 fusion proteins in the cell, we conducted
Western blot analysis to detect the CyaA portions of the fusion pro-
teins. We detected VirB6 fusion proteins only in cells in which
b-galactosidase activity was detected suggesting that the other
fusion proteins may not be expressed or not be stable.
Interestingly, the VirB10-CyaA fusion protein was also detected
only in cells which b-galactosidase activity was detected, suggest-
ing that VirB10 and its interacting domains from VirB6 as well as
VirB8 mutually stabilize each other. Whereas the negative results
with full-length VirB6 and other fusion proteins could be due to
misfolding or low expression, the positive results in case of VirB6
1–58 and 1–168 fusions strongly suggest that this part of VirB6
contains a VirB10 binding site. In order to better deﬁne the region
in VirB6 that interacts with VirB10, we next conducted in vitro
FRET experiments with synthetic VirB6 peptides and the periplas-
mic domain of VirB10.
3.4. The VirB6 N-terminal domain interacts with VirB10 in vitro
Fluorescence resonance energy transfer (FRET) is a widely used
method to analyze interactions between proteins. We used this
approach to explore speciﬁc interactions between different
VirB6-derived peptides and the periplasmic domain of VirB10.
VirB6-derived synthetic peptides covering amino acids 10–33
(N-terminus, peptide I) and 100–143 (central periplasmic loop,
peptide II) were chosen to represent potential interaction sites
identiﬁed by phage display and the BTH assay. A third synthetic
peptide comprising amino acids 301–329 (C-terminus, peptide
III), which according to the predicted topology would be located
in the cytoplasm, was used as a negative control. They were labeled
via N-terminal Cys residues with acceptor ﬂuorophore (Alexa ﬂuor
456) and VirB10 was labeled with donor ﬂuorophore (Alexa ﬂuor
488). Fluorescence emission of donor-labeled VirB10 wasmeasured upon increasing concentrations of acceptor-labeled
VirB6 peptides. Addition of the peptide corresponding to the
N-terminal domain of VirB6 increased FRET efﬁciency (reduced
donor emission) with an apparent KD value of 4 lM while the
peptides corresponding to the central periplasmic loop and the
C-terminus did not impact donor emission (Fig. 5). These results
agree with the results of the phage display and BTH assays suggest-
ing that the N-terminal region comprises an interaction site with
VirB10.
3.5. VirB6 peptides that interact with VirB10 or VirB8 do not disrupt
the VirB8 and VirB10 interactions
Considering that the N-terminal peptide interacts with VirB10,
the central VirB6 peptide interacts with VirB8 [7] and that VirB8
also interacts with VirB10 [24], we reasoned that these interactions
may impact each other. To test this possibility, we conducted FRET
assays with donor and acceptor pairs switched accordingly. VirB10
was labeled with the donor ﬂuorophore (Alexa ﬂuor 488) while
VirB8 was labeled with the acceptor ﬂuorophore (Alexa ﬂuor
546). The titration curve indicated a KD value of 0.5 lM, which is
in the same range of our previous data [24] (Fig. 6A). Next, the efﬁ-
ciency of energy transfer was assessed in the presence of unlabeled
VirB6 N-terminal peptide (Fig. 6A) and of unlabeled VirB6 central
peptide (Fig. 6B). Neither of these peptides affected the energy
transfer between VirB10 and VirB8 suggesting that none of the
two VirB6-derived peptides affects the interaction between VirB8
and VirB10. Finally, we assessed whether there is an effect of
Fig. 6. Fluorescence resonance energy transfer between VirB10, VirB8 and VirB6-derived peptides. (A) Fluorescence emission of Alexa ﬂuor 488 (donor) chemically attached
to VirB10 was measured upon increasing concentrations of VirB8 labeled with Alexa ﬂuor 546 (acceptor) in the absence (ﬁlled symbols) and presence (empty symbols) of
VirB6 N-terminal peptide (amino acids 10–33) or (B) VirB8-interacting central VirB6 peptide (amino acids 100–143). (C) Fluorescence emission of Alexa ﬂuor 488 (donor)
chemically attached to VirB10 was measured upon increasing concentrations of VirB6 N-terminal peptide (amino acids 10–33) labeled with Alexa ﬂuor 546 (acceptor) in the
absence (ﬁlled symbols) or presence (empty symbols) of unlabeled wild type VirB8. (D) Fluorescence emission of Alexa ﬂuor 488 (donor) chemically attached to VirB8 was
measured upon increasing concentrations of VirB6 central peptide (amino acids 100–143) labeled with Alexa ﬂuor 546 (acceptor) in the absence (ﬁlled symbols) or presence
(empty symbols) of unlabeled wild type VirB10. FRET efﬁciencies were calculated as 1  (F0/F) where F0 and F are the donor emission in the presence and absence of the
acceptor, respectively.
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central peptide-VirB8) interaction. Here, the donor ﬂuorophore
was attached to VirB10 and the acceptor was attached to the
VirB6 N-terminal peptide. The effects of the addition of unlabeled
VirB8 were assessed. An equivalent setup was used to assess an
effect of VirB10 on VirB6 central peptide-VirB8 interaction, i.e.,
donor-labeled VirB8, acceptor-labeled VirB6 central peptide, unla-
beled VirB10. No effects were detected on the interaction of any of
the proteins with the corresponding peptide from VirB6
(Fig. 6C and D). The in vitro conditions probably mimick the
in vivo situation only partly, but these results suggest that VirB6
is able to interact with VirB8 and VirB10 simultaneously in a
non-competitive fashion. The interactions between these three
proteins are likely very important for the dynamics of T4SS assem-
bly and our results may also help understanding the results from
previous work. When the pKM101 homologs of VirB7, VirB8,
VirB9 and VirB10 were overexpressed in an operon a stable com-
plex of VirB7, VirB9 and VirB10 formed, but VirB8 did not form part
of this complex [4]. On the contrary, when VirB3 to VirB10 homo-
logs from plasmid R388 were overexpressed and puriﬁed, VirB8
formed part of the resulting complex [5]. Given that VirB6 interacts
both with VirB8 and with VirB10 it could stabilize the interaction
between these proteins in the natural biological context explaining
the presence of VirB8 in the VirB3-VirB10 complex. This transient
interaction could in turn mediate the substrate transfer from VirB6
and VirB8 to VirB9 and VirB2 for which VirB10 is absolutely
required [10].
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